China pharma firms turn to local reagent suppliers to cut costs and delivery times
By Andrew Silver SHANGHAI (Reuters) -Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local manufacturers, industry executives and managers said, as they seek to cut costs and delivery times. Western reagent suppliers including U.S.-based Thermo Fisher Scientific and Germany’s Merck have profited in the world’s…
